Sunayan Ray work email
- Valid
- Valid
Sunayan Ray personal email
With a PhD in Biochemistry and Molecular Biology and over 12 years of experience in gene editing, gene therapy, and stem cell research, I am an expert in developing innovative solutions for aging-related diseases. I have a strong background in using cutting-edge tools and techniques such as CRISPR, RNAi, and AAV, and applying them to various disease contexts and models.As a Senior Scientist at Rejuvenate Bio, I led a team of talented scientists and engineers to design, optimize, and validate gene editing tools and delivery systems for stem cell and organoid models, as well as animal and human trials. I contributed to multiple publications, patents, and presentations on the applications and mechanisms of gene editing and gene therapy, and collaborated with leading experts and organizations in the field. I also established cell line engineering SOPs, drug screening protocols, and product development documentation in accordance with GXP guidelines. My passion for molecular biology and biotechnology drives me to explore new frontiers in gene editing and gene therapy, and to advance the science and practice of anti-aging therapies. My goal is to improve the quality of life for millions of people by developing safe and effective treatments for aging and age-related diseases.
-
Senior ScientistRejuvenate Bio Nov 2021 - Dec 2022UsDeveloped and established cell line engineering SOPs in AAV production.● Designed whole genome gRNA screening methods and optimized vectors with promotor/enhancer screening forenhanced AAV production yields and gene therapy deliveries.● Contributed to target identification for gene therapy● Collaborated interdepartmentally on tech transfer and product development documentation in accordance to GXPguidelines to external CRO companies.● Recognized for consistently taking initiative and completing deliverables before deadlines. -
Scientist IiInvivoscribe Feb 2019 - Nov 2021San Diego, California, Us● Established genetic engineering lab to bring CRISPR-mediated gene editing capabilities in-house.● Created modified cancer cell lines to create leukemia-significant mutations and support assay development.● Screened and identified effective clonal population of the significant.● Assisted in establishing drug screening and pharmacokinetics studies for new Invivoscribe Therapeutics division. -
Postdoctoral ResearcherUcsd May 2016 - Feb 2019Project title: “Cell engineering of iPSCs to develop and study human retina.” Progress in the retinal stem cell field is hampered by a lack of cell based reporter tools to monitor development. Towards this goal I am developing gene-editing tools to tag fluorescent reporters to genes that are expressed in the retinas at the different stages. Such tools will allow us to monitor the presence / absence of photoreceptor and ganglion cells which will in turn facilitate studies of eye development and disease.Project title: “Disease modeling using CRISPR-Cas9 edited iPSCs.” I study pluripotent stem cells to advance our knowledge of human retinal development and retinal disease. Using this state-of-the-art gene editing method such as CRISPR-Cas9, I modify human iPSC and ESC cells as the starting point for investigating the basic biology of retinal photoreceptors as well as the pathogenesis that occurs during retinal dystrophy. My goal also will be to characterize 3D mini-retinas in a dish using live cell imaging of fluorescent reporter cells and screen for compounds that modulate pathways relevant to retinal development.Project Title: “Functional analysis of iPSC derived retinas fused to brain organoids” This is a collaborative project, an interdisciplinary approach to building a retina-brain circuit. I am using strengths of stem cell biology and genetic engineering and neuroscience to achieve bridging the often separate worlds of retina and brain research. It is also the first attempt that we are aware to functionally integrate these two systems. The data from this new platform is expected to open up new funding opportunities from the NIH for studies of more specific disease models, such as for AMD, glaucoma or childhood onset Lebers congenital amaurosis (LCA). -
Postdoctoral Research FellowUcla Sep 2013 - Jun 2016Los Angeles, Ca, UsProject title: “Mice infection and pathogenesis of LC1 double homologous knock-in viable mutants of Trypanosoma brucei.”I have applied molecular cloning, live video microscopy and a mice infection model to determine the cellular and molecular role of cilium/flagellar function and pathogenesis in the eukaryotic pathogen, Trypanosoma brucei. In my project, I was successfully able to develop stable endogenous homologous knock-in mutants in Trypanosomes, and showed that these mutants demonstrated a severe motility defect in blood as well as severe virulence defect, contrary to the earlier studies published using RNAi model. Along with actively doing research, my responsibilities also included general lab maintenance. I have also mentored 1 graduate student, 2 undergraduates and 1 high school student. -
Research Associate In The Department Of Genetics And BiochemistryClemson University Sep 2008 - Aug 2013Clemson, Sc, UsProject Title: “Biochemical investigation into initiation of fatty acid synthesis in the African Trypanosomes.” My work included understanding the regulation of fatty acid synthesis in Trypanosomes. Trypanosoma brucei readily acquires fatty acids from its hosts. When host supply is limited, T.brucei synthesizes its own fatty acids. Environmental regulation of FAS would allow preferential use of host fatty acids, and turn on FAS only when host supply is insufficient. My dissertation work established important background on the regulation of T. brucei FA synthesis. I determined the key enzyme for fatty acid synthesis is modified at translational level and post-translational modification. -
Technical Research AssistantDepartment Of Genetics, Delhi University Aug 2007 - Jul 2008Project title: “siRNA approach to prevent fungal pathogenesis and expression analysis using micro array.”Facilitated studies on the genetic manipulation of tomato plants, and the genetic and biochemical characterization of the engineered plant lines.
-
Project AssistantBiotechnology R&D Lab Of Jubilant Organosys Limited Jan 2002 - Jul 2002“Strain improvement of yeast for alcohol production.”My work included maintenance of cell culture and biochemical analysis of lab-scale, large-scale and industry-scale reactants and products.
Sunayan Ray Skills
Sunayan Ray Education Details
-
Clemson UniversityBiochemistry And Molecular Biology -
University Of California, San Diego - Rady School Of ManagementGeneral -
Grd Institute Of BiotechnologyBiotechnology
Frequently Asked Questions about Sunayan Ray
What is Sunayan Ray's role at the current company?
Sunayan Ray's current role is Innovative scientist and leader with 9+ years of building, designing, and optimizing gene editing tools for stem cell and gene therapy..
What is Sunayan Ray's email address?
Sunayan Ray's email address is su****@****ibe.com
What schools did Sunayan Ray attend?
Sunayan Ray attended Clemson University, University Of California, San Diego - Rady School Of Management, Grd Institute Of Biotechnology.
What are some of Sunayan Ray's interests?
Sunayan Ray has interest in Social Services, Health.
What skills is Sunayan Ray known for?
Sunayan Ray has skills like Biochemistry, Molecular Cloning, Molecular Biology, Cell Culture, Cell Biology, Biotechnology, Pcr, Characterization, Genetics, Microscopy, Tissue Culture, Protein Expression.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial